We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Kate Robinson

Kate Robinson

Editorial Assistant

Contact Us

Kate graduated from Sheffield Hallam University with a bachelor's degree in biomedical sciences in 2020. During her studies she developed a passion for science communication and after graduating, began a science blog in order to continue writing about trending science news and topics of interest. She joined the editorial team at Technology Networks in 2021. In her role as editorial assistant Kate supports the publication’s in-house writers, produces scientific content across all communities and works closely with the managing editor to help coordinate commissioned pieces.


Latest Content
Gut Instinct Should Not Play a Part in Drug Repurposing
Article

Gut Instinct Should Not Play a Part in Drug Repurposing

Technology Networks spoke to Ahmad Besaratinia, PhD, professor of Research Population and Public Health Sciences, Keck School of Medicine of USC to find out more about drug repurposing and the dangers that come with using a drug without fully assessing its potential for harm.
Brooks Automation To Unify Services Under Azenta Life Sciences
Industry Insight

Brooks Automation To Unify Services Under Azenta Life Sciences

Technology Networks spoke to Linda De Jesus, senior vice president and chief commercial officer at Azenta Life Sciences to find out more about the announcement and how this will help drive innovation with greater speed and accuracy.
Spatial Biology
Infographic

Spatial Biology

Download this infographic to discover how spatial biology can elucidate biological activity in relation to environment, is utilized in neuroscience and cancer research, and can be explored using various technologies.
Novel Biomarkers for the Treatment of Non-Small Cell Lung Cancer
Article

Novel Biomarkers for the Treatment of Non-Small Cell Lung Cancer

Technology Networks spoke to Dr. Alberto Cruz Bermúdez, postdoctoral investigator at Puerta de Hierro Majadahonda University Hospital to learn more about the current state of non-small cell lung cancer therapies and the discovery of two novel biomarkers.
All Cancers May Fall Into One of Two Classes
Article

All Cancers May Fall Into One of Two Classes

Technology Networks spoke with Dr. Rod Bremner to find out more about a cancer classification technique and the possible implications for future cancer treatments.
Sustainability Grant Awarded to Honey Bee Research
Industry Insight

Sustainability Grant Awarded to Honey Bee Research

Technology Networks spoke with Dr. Bertram Brenig and Illumina to find out more about how studying genetic differences in honey bees will improve breeding programs, and how Illumina will support this research.
Detecting a Change in Disease Trajectory With Synthetic Molecules
Industry Insight

Detecting a Change in Disease Trajectory With Synthetic Molecules

Technology Networks spoke with Dr. Caroline Loew, CEO of Glympse Bio to learn more about the use of activity-based biosensors in fibrotic disease.
A No-Code Cloud Platform for Life Science Research
Industry Insight

A No-Code Cloud Platform for Life Science Research

Technology Networks spoke to Guy Levy-Yurista, CEO of Synthace to find out how the new cloud-based solution can support life science research.
A Thermostable Needle-Free Vaccine for Cholera
Article

A Thermostable Needle-Free Vaccine for Cholera

Technology Networks spoke to Hiroshi Kiyono, DDS, PhD, from the Institute of Medical Science at the University of Tokyo who is currently also affiliated with Chiba University and University of California, San Diego, to find out more about MucoRice-CTB, a room-temperature stable oral vaccine being developed using genetically modified rice plants.
Developing Thermostable Vaccines To Improve Accessibility Worldwide
Industry Insight

Developing Thermostable Vaccines To Improve Accessibility Worldwide

We spoke to Ozgur Tuncer, chief executive officer of Stablepharma to find out more about the company’s thermo-stabilization technology called StablevaX™ and how it is being used as a complementary technology for COVID-19 vaccines. He also highlights the impact “fridge-free” vaccines could have more generally.
Advertisement